Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;32(5):828-33.
doi: 10.2337/dc08-1699. Epub 2009 Feb 5.

Elevated A1C in adults without a history of diabetes in the U.S

Elizabeth Selvin  1 , Hong Zhu, Frederick L Brancati
Affiliations

Elevated A1C in adults without a history of diabetes in the U.S

Elizabeth Selvin et al. Diabetes Care. 2009 May.

Abstract

Objective: The purpose of this study was to examine the prevalence and correlates of elevated A1C in a large, nationally representative sample of adults without diabetes in the U.S.

Research design and methods: We analyzed data from 15,934 participants aged >or=20 years without diagnosed diabetes who had A1C measurements in the 1999-2006 National Health and Nutrition Examination Survey, a cross-sectional and nationally representative sample of the U.S. population.

Results: The overall prevalence of A1C >6% was 3.8%, corresponding to 7.1 million adults without diabetes in the U.S. population. Approximately 90% of these individuals had fasting glucose >or=100 mg/dl. Older age, male sex, non-Hispanic black race/ethnicity, hypercholesterolemia, higher BMI, and lower attained education were significantly associated with having a higher A1C level even among individuals with normal fasting glucose (<100 mg/dl) and after multivariable adjustment.

Conclusions: A single elevated A1C level (A1C >6%) is common in the general population of adults without a history of diabetes and is highly reliable for the detection of elevated fasting glucose. Nondiabetic adults with elevated A1C are likely to have impaired fasting glucose and an array of other risk factors for type 2 diabetes and cardiovascular disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Count in millions (95% CI) of persons at different A1C cut points in the U.S. 2000 Census population aged ≥20 years without diabetes.
Figure 2
Figure 2
Weighted smoothed histogram comparing distributions of A1C by fasting glucose category, adults aged ≥20 years without diagnosed diabetes, U.S. 1992–2006.
See this image and copyright information in PMC

References

    1. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ: Utility of hemoglobin A1c in predicting diabetes risk. J Gen Internal Med 2004; 19: 1175– 1180 - PMC - PubMed
    1. Ko GT, Chan JC, Tsang LW, Cockram CS: Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000; 23: 1770– 1773 - PubMed
    1. Pradhan AD, Rifai N, Buring JE, Ridker PM: Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007; 120: 720– 727 - PMC - PubMed
    1. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E: the DESIR Study Group. Use of HbA1c in predicting progression to diabetes in french men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619– 1625 - PubMed
    1. Inoue K, Matsumoto M, Kobayashi Y: The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 2007; 77: 451– 458 - PubMed

Publication types

Substances